Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 4/20 | 0.33 |
| ▸ | NPY4R | P50391 | 2/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | GLP1R | P43220 | 7/20 | 0.32 |
| ▸ | CCKAR | P32238 | 1/20 | 0.32 |
| ▸ | CCKBR | P32239 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | CPA2 | P48052 | 1/20 | 0.31 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
| ▸ | EPOR | P19235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26066857 | 0.87 | HDAC8 (0.39) | NPY1RNPY4RCCKARCCKBRHDAC1 | |
| SCHEMBL26066853 | 0.87 | HDAC8 (0.39) | NPY1RNPY4RCCKARCCKBRHDAC1 | |
| SCHEMBL25218460 | 0.85 | HDAC8 (0.36) | NPY1RNPY4RGLP1RCCKARCCKBR | |
| SCHEMBL26066952 | 0.81 | ALDH1A1 (0.39) | ADORA3HDAC1HDAC7KIF11EPOR | |
| SCHEMBL25242026 | 0.78 | FOLH1 (0.37) | HDAC1HDAC7 | |
| SCHEMBL25242024 | 0.78 | FOLH1 (0.37) | HDAC1HDAC7 | |
| SCHEMBL19732156 | 0.77 | FOLH1 (0.37) | HDAC1HDAC7 | |
| SCHEMBL25245450 | 0.76 | FOLH1 (0.35) | GLP1RHDAC1HDAC7 | |
| SCHEMBL27189832 | 0.75 | HDAC8 (0.34) | GLP1RHDAC1HDAC7 | |
| SCHEMBL27190126 | 0.75 | HDAC8 (0.34) | GLP1RHDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270867-A1 | CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME | PINOTBIO, INC. (KR) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270867-A1 | CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME | SLC46A1, SLC47A1, FOLR1 | NPY1R 3532/4885NPY4R 4592/4885TLR2 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.